Renhe Pharmacy: Announcement on the Company's subsidiary obtaining a drug registration certificate
Renhe Pharmacy: 000650 Renhe Pharmaceutical Investor Relations Management Information 20240522
Renhe Pharmacy: Legal Opinion on Renhe Pharmaceutical's Phase II Employee Stock Ownership Plan
Renhe Pharmacy: Announcement on participating in the 2024 Investor Online Group Reception Day
Renhe Pharmacy: 000650 Renhe Pharmaceutical Investor Relations Management Information 20240510
Renhe Pharmacy: Audit opinion of the board of supervisors on the company's second employee stock ownership plan
Renhe Pharmacy: Announcement of Resolutions of the 20th Interim Meeting of the 9th Board of Directors of the Company
Renhe Pharmacy: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Renhe Pharmacy: Summary of Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft) (Revised Draft)
Renhe Pharmacy: Instructions of the board of directors on the company's second employee stock ownership plan (draft) (revised draft) in accordance with the relevant provisions of the “Guiding Opinions on Implementing Pilot Employee Stock Ownership Plans for Listed Companies”
Renhe Pharmacy: Announcement of Resolutions of the 14th Meeting of the 9th Board of Supervisors of the Company
Renhe Pharmacy: Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft) (Revised Draft)
Renhe Pharmacy: 2024 First Quarter Report
Renhe Pharmacy: Instructions of the board of directors that the second phase of the company's employee stock ownership plan (draft) complies with the relevant provisions of the “Guiding Opinions on Implementing Pilot Employee Stock Ownership Plans by Listed Companies”
Renhe Pharmacy: Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft)
Renhe Pharmacy: Summary of Renhe Pharmaceutical Co., Ltd. Phase II Employee Stock Ownership Plan (Draft)
Renhe Pharmacy: Audit opinion of the board of supervisors on the company's second employee stock ownership plan
Renhe Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors
Renhe Pharmaceutical: 2023 Annual Audit Report
Renhe Pharmaceutical: Report of the Board of Directors on the Evaluation of the Performance of Accounting Firms in 2023
No Data